| Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy S Kraler, MC Blaser, E Aikawa, GG Camici, TF Luescher European heart journal 43 (7), 683-697, 2022 | 118 | 2022 |
| Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease A Akhmedov, T Sawamura, CH Chen, S Kraler, D Vdovenko, TF Lüscher European heart journal 42 (18), 1797-1807, 2021 | 82 | 2021 |
| Multi-omics approaches to define calcific aortic valve disease pathogenesis MC Blaser, S Kraler, TF Lüscher, E Aikawa Circulation research 128 (9), 1371-1397, 2021 | 71 | 2021 |
| Inflammation in Metabolic Cardiomyopathy FA Wenzl, S Ambrosini, SA Mohammed, S Kraler, TF Lüscher, ... Frontiers in Cardiovascular Medicine, 1194, 2021 | 64 | 2021 |
| Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational … FA Wenzl, S Kraler, G Ambler, C Weston, SA Herzog, L Räber, O Muller, ... The Lancet 400 (10354), 744-756, 2022 | 63 | 2022 |
| Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes S Kraler, FA Wenzl, G Georgiopoulos, S Obeid, L Liberale, ... European heart journal 43 (19), 1849-1860, 2022 | 39 | 2022 |
| Ageing and longevity genes in cardiovascular diseases L Liberale, S Kraler, GG Camici, TF Lüscher Basic & clinical pharmacology & toxicology 127 (2), 120-131, 2020 | 32 | 2020 |
| Resilience of the internal mammary artery to atherogenesis: shifting from risk to resistance to address unmet needs S Kraler, P Libby, PC Evans, A Akhmedov, MO Schmiady, M Reinehr, ... Arteriosclerosis, thrombosis, and vascular biology 41 (8), 2237-2251, 2021 | 31 | 2021 |
| Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cycling S Ljubojević-Holzer, S Kraler, N Djalinac, M Abdellatif, J Voglhuber, ... Cardiovascular research 118 (6), 1492-1505, 2022 | 30 | 2022 |
| TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodies A Akhmedov, M Crucet, B Simic, S Kraler, NR Bonetti, C Ospelt, O Distler, ... Cardiovascular Research 118 (1), 254-266, 2022 | 22 | 2022 |
| Repurposing Colchicine to Combat Residual Cardiovascular Risk: The LoDoCo2 Trial S Kraler, FA Wenzl, TF Lüscher European Journal of Clinical Investigation, 2020 | 16 | 2020 |
| JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study L Liberale, YM Puspitasari, S Ministrini, A Akhmedov, S Kraler, NR Bonetti, ... European Heart Journal 44 (20), 1818-1833, 2023 | 15 | 2023 |
| Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress K Yang, S Velagapudi, A Akhmedov, S Kraler, T Lapikova-Bryhinska, ... Cardiovascular Research 119 (12), 2190-2201, 2023 | 12 | 2023 |
| History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbidities A Denegri, G Magnani, S Kraler, F Bruno, R Klingenberg, F Mach, ... International journal of cardiology 382, 76-82, 2023 | 10 | 2023 |
| Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: a case-cohort analysis S Kraler, FA Wenzl, J Vykoukal, JF Fahrmann, MY Shen, DY Chen, ... Atherosclerosis 376, 43-52, 2023 | 9 | 2023 |
| Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes FA Wenzl, F Bruno, S Kraler, R Klingenberg, A Akhmedov, S Ministrini, ... European heart journal 44 (38), 3859-3871, 2023 | 8 | 2023 |
| SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits A Preda, F Montecucco, F Carbone, GG Camici, TF Lüscher, S Kraler, ... Cardiovascular Research 120 (5), 443-460, 2024 | 7 | 2024 |
| Calcific aortic valve disease: novel insights into nitric oxide signalling S Kraler, V Garg, A Akhmedov European heart journal 43 (17), 1665-1667, 2022 | 7 | 2022 |
| SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammation L Liberale, S Kraler, YM Puspitasari, NR Bonetti, A Akhmedov, S Ministrini, ... Cardiovascular Research 119 (3), 843-856, 2023 | 6 | 2023 |
| Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans S Kraler, C Balbi, D Vdovenko, T Lapikova-Bryhinska, GG Camici, ... Cardiovascular research 119 (17), 2729-2742, 2023 | 5 | 2023 |
Camici G.G.Director, Center for Molecular Cardiology, University of ZurichVerified email at uzh.ch